BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20332215)

  • 1. Relaxin enhances S100A4 and promotes growth of human thyroid carcinoma cell xenografts.
    Radestock Y; Willing C; Kehlen A; Hoang-Vu C; Hombach-Klonisch S
    Mol Cancer Res; 2010 Apr; 8(4):494-506. PubMed ID: 20332215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
    Radestock Y; Hoang-Vu C; Hombach-Klonisch S
    Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
    Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
    Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
    Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model.
    Shi Y; Zou M; Collison K; Baitei EY; Al-Makhalafi Z; Farid NR; Al-Mohanna FA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2373-9. PubMed ID: 16551737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INSL3 has tumor-promoting activity in thyroid cancer.
    Hombach-Klonisch S; Bialek J; Radestock Y; Truong A; Agoulnik AI; Fiebig B; Willing C; Weber E; Hoang-Vu C; Klonisch T
    Int J Cancer; 2010 Aug; 127(3):521-31. PubMed ID: 19950223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin (alpha6beta4) signals through Src to increase expression of S100A4, a metastasis-promoting factor: implications for cancer cell invasion.
    Kim TH; Kim HI; Soung YH; Shaw LA; Chung J
    Mol Cancer Res; 2009 Oct; 7(10):1605-12. PubMed ID: 19808905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells.
    Radestock Y; Hoang-Vu C; Hombach-Klonisch S
    Ann N Y Acad Sci; 2005 May; 1041():462-9. PubMed ID: 15956747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
    Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
    Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.
    Jendrzejewski J; Thomas A; Liyanarachchi S; Eiterman A; Tomsic J; He H; Radomska HS; Li W; Nagy R; Sworczak K; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1370-7. PubMed ID: 26274343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
    Wang L; Wang X; Liang Y; Diao X; Chen Q
    Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep‑2 cells.
    Liu J; Fu S; Xu Y; Zheng Z
    Mol Med Rep; 2014 Sep; 10(3):1389-94. PubMed ID: 24969174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
    Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivo.
    Zhang K; Yu M; Hao F; Dong A; Chen D
    Cancer Biomark; 2016 Sep; 17(3):281-291. PubMed ID: 27802204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
    Li HJ; Chen YX; Wang Q; Zhang YG
    Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.
    Jin T; Zhang Z; Yang XF; Luo JS
    Asian Pac J Cancer Prev; 2015; 16(7):2883-7. PubMed ID: 25854377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth.
    Ochiya T; Takenaga K; Endo H
    Angiogenesis; 2014 Jan; 17(1):17-26. PubMed ID: 23929008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.